ArticleJCEM case reports2025
A Case of Spontaneously Resolving Cushing Disease.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of spontaneous resolution of Cushing disease (CD). A 20-year-old female individual, previously healthy, was referred for investigation of galactorrhea and a prolactin level of 31 ng/mL (<20 ng/mL) (SI: 31 µg/L, <20 µg/L). A magnetic resonance imaging (MRI) scan revealed an 11 mm pituitary lesion. Cabergoline was commenced to address symptomatic hyperprolactinemia. Over the following months, signs of hypercortisolism evolved. Initial tests revealed a positive 1-mg dexamethasone suppression test (DST), prompting further evaluation. Midnight salivary and 24-hour urinary free cortisol tests confirmed hypercortisolism, consistent with a pituitary source which was confirmed with a peripheral corticotropin-releasing hormone (CRH) stimulation test. While cabergoline successfully resolved the galactorrhea, an MRI scan 6 months later showed an increase in the pituitary lesion's size, leading to neurosurgical referral. However, a preoperative MRI surprisingly revealed complete resolution of the pituitary mass, which coincided with the normalization of hypercortisolism symptoms and laboratory results. This rare case of spontaneous remission, while possibly influenced by cabergoline or undetected pituitary apoplexy, contributes valuable insights into the unpredictable nature of CD and its treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.